Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion

Surgery

Volumn 122, Issue 2, 1997, Pages 288-294

  Lane, John S ^b   Todd, Karen E ^b   Lewis, Michael P N ^b   Gloor, Beat ^b   Ashley, Stanley W ^b   Reber, Howard A ^b   McFadden, David W ^b   Chandler, Charles F ^a  

^a UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CETRIMIDE; INTERLEUKIN 10; INTERLEUKIN 6; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE AMPLIFICATION; HISTOLOGY; INFLAMMATION; INTESTINE BLOOD FLOW; INTESTINE ISCHEMIA; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY;

EID: 0030875885     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90020-9     Document Type: Conference Paper

References (21)

1. Deitch, EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990;125:403-4.
2. Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981;81:22-9.
3. Deitch EA, Bridges W, Baker J, MaJ, Ma L, Grisham MB, et al. Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation. Surgery 1988;104:191-8.
4. Yao YM, Sheng ZY, Yan Y, Tian HM, Wan YP, Lu LR, et al. The potential etiologic role of tumor necrosis factor in mediating multiple organ dysfunction in rats following intestinal ischemia-reperfusion injury. Resuscitation 1995;29:157-68.
5. Roumen RMH, Hendriks T, Ven-Jongeknjgg J, Nieuwwenenhuijzen GAI, Sauerwein RW, van der Meer JWM, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and sever blunt trauma. Ann Surg 1993;218:769-76.
6. Andrews P, Krinsky N. Quantitative determination of myeloperoxidase using tetramethylbenzidine as substrate. Anal Biochem 1982;127:346-50.
7. Chui CJ, McArdle AH, Brown R, Scott H, Gurd F. Intestinal mucosal lesion in low-flow states. Arch Surg 1970;101:478-83.
8. Fiorentino D, Zlotnik A, Mosmann T, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
9. Howard M, O'Garra A, Ishida H, DeWaal Malefyt R, DeVries J. Biological properties of interleukin-10. J Clin Immunol 1992:12:61-74.
10. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177:1205-08.
11. Rongione AJ, Kusske AM, Ashley SW, Reber HA, McFadden DW. Interleukin 10 reduces severity of acute pancreatitis in the rat. Gastroenterology 1995;112:960-7.
12. Kusske AM, Rongione AJ, Ashley SW, McFadden DW, Reber HA. Interleukin 10 (IL-10) prevents death in lethal necrotizing pancreatitis (AI) in mice. Surgery 1996;120:284-8..
13. Kusske AM, Rongione AJ, Reber HA. Cytokines and acute pancreatitis. Gastroenterology 1996;110:639-42.
14. Marchant A, Deviere J, Byl B. Interleukin 10 production during septicemia. Lancet 1994;343:707-8.
15. Seekamp A, Warren JS, Remick DG, Till GO, Ward PA. Requirements for tumor necrosis factor-α and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol 1993;143:453-63.
16. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10.
17. Youker K, Smith DW, Anderson DC, Miller D, Michael LH, Rossen RD, et al. Neutrophil adherence to isolated adult cardiac myocytes. J Clin Invest 1992;89:602-9.
18. Biffl WL, Moore EE, More FA, Peterson VM. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996;224:647-64.
19. Moore EE, Moore FA, Franciose RJ, Kin FJ, Biffl WL, Benerjee A. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma 1994;37:881-7.
20. Krawisz JE, Sharon P, Steson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-50.
21. Laster SM, Wood JG, Gooding LR. Tumor necrosis factor can induce both apoptitic and necrotic forms of cell lysis. J Immunol 1988;141:2629-34.